(VERA) Vera Therapeutics - Performance -32.3% in 12m
VERA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
23.94%
#17 in Peer-Group
Rel. Strength
15.76%
#6495 in Stock-Universe
Total Return 12m
-32.29%
#102 in Peer-Group
Total Return 5y
105.65%
#13 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 49.75 USD |
| 52 Week Low | 18.86 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 71.69 |
| Buy/Sell Signal +-5 | 1.45 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: VERA (-32.3%) vs XBI (-7.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.11% | 68.3% | 77.5% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.3% | -6.89% | 148% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.9% | -1.4% | 35.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
0.57% | 33% | -5.3% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.89% | -5.88% | 1.36% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.2% | 59.2% | -5.89% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.66% | 61.7% | -9.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.23% | 38.8% | 14.5% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: VERA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for VERA
| Total Return (including Dividends) | VERA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -25.49% | 4.38% | 4.99% |
| 3 Months | 0.25% | 5.22% | 10.23% |
| 12 Months | -32.29% | -7.16% | 14.42% |
| 5 Years | 105.65% | -24.61% | 110.17% |
| Trend Score (consistency of price movement) | VERA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -7.1% | 3.5% | 79.1% |
| 3 Months | 12.2% | 75.7% | 95.5% |
| 12 Months | -67.8% | -85.1% | 44.7% |
| 5 Years | 48% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th5.50 | -28.61% | -29.03% |
| 3 Month | %th44.50 | -4.72% | -9.05% |
| 12 Month | %th50.00 | -27.07% | -40.83% |
| 5 Years | %th97.50 | 207.29% | 30.05% |
FAQs
Does Vera Therapeutics (VERA) outperform the market?
No,
over the last 12 months VERA made -32.29%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.16%.
Over the last 3 months VERA made 0.25%, while XBI made 5.22%.
Performance Comparison VERA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
VERA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.7% | -30.5% | -50.7% | -47% |
| US NASDAQ 100 | QQQ | -0.3% | -30.9% | -52.2% | -46% |
| German DAX 40 | DAX | 0.2% | -24.9% | -62.3% | -63% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2% | -29.7% | -51.2% | -50% |
| Hongkong Hang Seng | HSI | 1.2% | -32.6% | -69.2% | -69% |
| India NIFTY 50 | INDA | 0.4% | -27.4% | -48.1% | -32% |
| Brasil Bovespa | EWZ | -3.4% | -33.5% | -73.6% | -46% |
VERA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.7% | -31.2% | -55% | -59% |
| Consumer Discretionary | XLY | -1.8% | -28.4% | -43.8% | -51% |
| Consumer Staples | XLP | -1% | -25.4% | -50.2% | -42% |
| Energy | XLE | -1.4% | -31.6% | -45.9% | -31% |
| Financial | XLF | -0.9% | -29.1% | -53.9% | -60% |
| Health Care | XLV | 0.4% | -28% | -43.2% | -28% |
| Industrial | XLI | -1.6% | -29.7% | -57.5% | -56% |
| Materials | XLB | -3.9% | -31.3% | -54.9% | -39% |
| Real Estate | XLRE | 0.1% | -26.4% | -49.3% | -45% |
| Technology | XLK | -0.3% | -34.5% | -53.7% | -44% |
| Utilities | XLU | 0.6% | -25% | -52% | -55% |
| Aerospace & Defense | XAR | -1% | -33% | -69% | -81% |
| Biotech | XBI | -0.4% | -29.9% | -36.6% | -25% |
| Homebuilder | XHB | -5.6% | -37.1% | -44.7% | -38% |
| Retail | XRT | -3.4% | -31% | -45.5% | -43% |
VERA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -1.7% | -34.2% | -42.2% | -25% |
| Natural Gas | UNG | 4.2% | -16.9% | -34.6% | -26% |
| Gold | GLD | 0.8% | -24.7% | -70% | -76% |
| Silver | SLV | 0.8% | -30.7% | -67.4% | -56% |
| Copper | CPER | -3% | -31.7% | -71.3% | -49% |
VERA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1% | -28.7% | -46.1% | -33% |
| iShares High Yield Corp. Bond | HYG | 0.8% | -27.4% | -48.8% | -43% |